Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Wall Street Journal
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that he has himself.